2014
DOI: 10.2174/1386207317666140321115128
|View full text |Cite
|
Sign up to set email alerts
|

E-Pharmacophore and Molecular Dynamics Study of Flavonols and Dihydroflavonols as Inhibitors Against DiHydroOrotate DeHydrogenase

Abstract: DiHydroOrotate DeHydrogenase [huDHODH] is a therapeutic target for Rheumatoid arthritis [RA]. Leflunomide [A771726] is a widely used synthetic inhibitor against huDHODH. We to find more efficient lead like compounds. A four featured E-Pharmacophore A1D4H6R7 was built based on the inhibitor A771726. This pharmacophore was validated by checking its ability to identify known highly active inhibitors of huDHODH and assigning higher fitness scores to them. A reverse validation was also performed where random 4 feat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Recently, rhamnazin is known to posses in vitro antiinflammatory activity acts as inhibitors against dihydroorotate dehydrogenase, 24 and rhamnazin from Callicarpa kwangtungensis Chun possessed antioxidant property. 14 More recently, rhamnazin from Caragana leucophloea Pojark revealed to have strong antioxidant capacity.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, rhamnazin is known to posses in vitro antiinflammatory activity acts as inhibitors against dihydroorotate dehydrogenase, 24 and rhamnazin from Callicarpa kwangtungensis Chun possessed antioxidant property. 14 More recently, rhamnazin from Caragana leucophloea Pojark revealed to have strong antioxidant capacity.…”
Section: Discussionmentioning
confidence: 99%
“…Compounds were ranked based on the fitness score above 1.5 [31], and those above this threshold were docked into the active site of the GSK3β.…”
Section: E-pharmacophore-based Screeningmentioning
confidence: 99%